Lilly Broadens Income Eligibility for Patient Assistance Programs
August 05 2009 - 8:00AM
PR Newswire (US)
Patients at 300 percent of the U.S. Federal Poverty Level, or even
higher for some programs, now qualify INDIANAPOLIS, Aug. 5
/PRNewswire-FirstCall/ -- In the midst of the down economy, many
Americans have seen their financial situations change - for the
worse - forcing them to make difficult sacrifices to afford
medications or detrimental decisions to stop taking medicines. On
Aug. 1, 2009, Lilly USA adjusted the income eligibility for its
most widely used patient assistance programs to allow enrollment of
eligible patients with incomes at or less than 300 percent of the
U.S. Federal Poverty Level. This is an income eligibility increase
from the previous 200 percent Federal Poverty Level. With this
change, the income eligibility limit for all Lilly owned or
supported patient assistance programs is set at, or above, 300
percent of the current Federal Poverty Level. As an example, the
new yearly eligible income limit for a family of two corresponds to
approximately $44,000. "By making these changes, we are addressing
a real concern for patients we have heard from in recent months.
Many have lost their jobs and insurance coverage and need our help
to stay on their medications," said John C. Lechleiter, Ph.D., Eli
Lilly and Company chairman, president and chief executive officer.
"Patients are our first priority. By relaxing the income guidelines
for Lilly's patient assistance programs, more patients will qualify
for Lilly's patient assistance programs." The income eligibility
adjustment is a long-term change for the programs, which over the
past three years have assisted more than 580,000 patients in the
United States and distributed medications valued at over $784
million. Globally, over the past three years, Lilly has donated
$883 million in products to patients and agencies throughout the
world. Patients who believe they qualify for any of Lilly's patient
assistance programs, or whose financial situation has changed from
their last tax filing or application to Lilly's programs, may
contact the applicable patient assistance program or visit
http://www.lilly.com/responsibility/programs to find out more
program information. Lilly's patient assistance programs Access to
affordable medications is a top priority for Lilly. This commitment
is exemplified by Lilly's various patient assistance programs,
which provide needy patients access to the company's portfolio of
medications. Lilly Cares(TM) Lilly Cares Foundation, Inc. created
and administers a patient assistance program that provides access
to most Lilly products for eligible U.S. residents. Through their
physicians, patients who are otherwise unable to obtain Lilly
medications may qualify for free medicines. To learn more or obtain
an application, call (800) 545-6962 or visit
http://www.lillycares.com/. LillyMedicareAnswers(TM)
LillyMedicareAnswers is a patient assistance program that provides
eligible Medicare recipients access to Lilly medications outside of
their Medicare Part D plan. To learn more or obtain an application,
call (877) RX-LILLY (1-877-795-4559) or visit
http://www.lillymedicareanswers.com/. Lilly Specialty Programs
Lilly offers additional patient assistance programs, such as Lilly
Camp Care Package Initiative, Lilly Oncology and other specialty
product programs. For more information about all patient assistance
programs, visit http://www.lilly.com/responsibility/programs.
Partnership for Prescription Assistance Lilly supports the
Partnership for Prescription Assistance, which brings together
America's pharmaceutical companies, doctors, other health care
providers, patient advocacy organizations and community groups to
match patients with public and private prescription assistance
programs for which they may be eligible for enrollment. Many of
these programs are offered by individual pharmaceutical companies.
For more information, call (888) 4PPA-NOW (888-477-2669) or visit
http://www.pparx.org/. About Eli Lilly and Company Lilly, a leading
innovation-driven corporation, is developing a growing portfolio of
pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent
scientific organizations. Headquartered in Indianapolis, Ind.,
Lilly provides answers - through medicines and information - for
some of the world's most urgent medical needs. Additional
information about Lilly is available at http://www.lilly.com/.
O-LLY (Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
DATASOURCE: Eli Lilly and Company CONTACT: Janice Chavers, Eli
Lilly and Company, +1-317-651-6253 (office), +1-317-612-4974
(cell),
Copyright